A hidden clue may explain why some mutated cells become cancerous and others don’t: how fast they divide. A new study from ...

cells, whereas mutations affecting KRAS or BRAF drive tumour formation from alveolar type 2 (AT2) cells. In the Rb-mutant tissue, the NE cells had the shortest cell cycle, whereas in tumours with ...

The Phase II trial will assess the therapy’s safety, tolerability and its activity across various biomarkers in IPF patients.

Tobacco-based products, including e-cigarettes, have gained popularity as perceived safer alternatives to traditional smoking despite their addictive nature. However, emerging evidence shows that ...

Modelling and Life and Health at the University of Bonn have presented their €100,000 research prize, entitled “Modelling for ...

Rein previously announced positive topline results from Cohort 2 (5 mg BID) of the Phase 1b clinical trial of LTI-03 in IPF, in which a positive trend was observed in seven out of eight biomarkers ...

An artificial intelligence (AI)-based model accurately classified pediatric sarcomas using digital pathology images alone, ...

Environmental and Occupational Exposure: Chronic inhalation of inorganic and organic particulates, such as silica, asbestos, ...

Pulmonary fibrosis (PF) is a progressive interstitial lung disease (ILD) characterized by excessive fibrotic tissue ...

A recent study reveals that dimethyl fumarate (DMF), a compound already approved for other inflammatory diseases, can prevent and alleviate ...